Trevi Therapeutics Inc (TRVI)
Healthcare
Biotechnology
18.30 $
-0.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Trevi Therapeutics Inc (TRVI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 83.7% of the shares are freely tradable; institutional investors hold 98.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
98.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.6%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
83.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
11.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
142Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| NEA Management Company, LLC | 9.31 | 13,222,228 | +0.0 | 03/31/2026 |
| BlackRock Inc | 7.21 | 10,240,186 | +1.1 | 03/31/2026 |
| Frazier Life Sciences Management, L.P. | 7.00 | 9,939,547 | -3.1 | 03/31/2026 |
| FMR Inc | 5.66 | 8,038,061 | +23.7 | 03/31/2026 |
| Vanguard Group Inc | 4.53 | 6,434,655 | +10.4 | 12/31/2025 |
| Wellington Management Company LLP | 3.65 | 5,189,088 | +52.4 | 03/31/2026 |
| Vivo Capital, LLC | 3.59 | 5,094,668 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.51 | 4,978,567 | +0.0 | 03/31/2026 |
| Marshall Wace Asset Management Ltd | 2.79 | 3,966,019 | -13.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.83 | 4,020,310 | +8.7 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.